Health
17 Oct 2026
AstraZeneca partners with insitro on $1.5B AI drug discovery
The UK‑Swedish pharma giant and the biotech will use AI to find new drugs for cardiometabolic diseases, aiming for exclusive rights and milestone payments.
Read moreTopic
#AstraZeneca
1 story